Similar articles

• Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.

  Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT, Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW; MIND Trial Investigators. Girard TD, et al. Crit Care Med. 2010 Feb;38(2):428-37. doi: 10.1097/ccm.0b013e3181c58715. Crit Care Med. 2010. PMID: 20095068 Free PMC article. Clinical Trial.
• Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role?

  Devlin JW, Skrobik Y. Devlin JW, et al. Harv Rev Psychiatry. 2011 Mar-Apr;19(2):59-67. doi: 10.3109/10673229.2011.565247. Harv Rev Psychiatry. 2011. PMID: 21425934 Review.
• Intravenous ziprasidone for treatment of delirium in the intensive care unit.

  Young CC, Lujan E. Young CC, et al. Anesthesiology. 2004 Sep;101(3):794-5. doi: 10.1097/00000542-200409000-00031. Anesthesiology. 2004. PMID: 15329607 No abstract available.
• Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.

  Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, Douglas IS, Malhotra A, Owens RL, Feinstein DJ, Khan B, Pisani MA, Hyzy RC, Schmidt GA, Schweickert WD, Hite RD, Bowton DL, Masica AL, Thompson JL, Chandrasekhar R, Pun BT, Strength C, Boehm LM, Jackson JC, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Bernard GR, Dittus RS, Ely EW; MIND-USA Investigators. Girard TD, et al. N Engl J Med. 2018 Dec 27;379(26):2506-2516. doi: 10.1056/NEJMoa1808217. Epub 2018 Oct 22. N Engl J Med. 2018. PMID: 30346242 Free PMC article. Clinical Trial.
• Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.

  Rea RS, Battistone S, Fong JJ, Devlin JW. Rea RS, et al. Pharmacotherapy. 2007 Apr;27(4):588-94. doi: 10.1592/phco.27.4.588. Pharmacotherapy. 2007. PMID: 17381385 Review.